Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) hit a new 52-week low on Monday . The company traded as low as GBX 26 ($0.34) and last traded at GBX 26.40 ($0.35), with a volume of 176637 shares trading hands. The stock had previously closed at GBX 28 ($0.37).
Beximco Pharmaceuticals Price Performance
The company has a fifty day moving average of GBX 35.92 and a 200-day moving average of GBX 37.71. The stock has a market cap of £102.61 million, a PE ratio of 300.00 and a beta of 0.64. The company has a current ratio of 1.80, a quick ratio of 0.37 and a debt-to-equity ratio of 14.73.
About Beximco Pharmaceuticals
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.
Featured Articles
- Five stocks we like better than Beximco Pharmaceuticals
- How is Compound Interest Calculated?
- 3 Small Cap Stocks That Insiders Are Buying
- Are Penny Stocks a Good Fit for Your Portfolio?
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
- Where to Find Earnings Call Transcripts
- 3 Must-Own Stocks for Bullish Investors in Today’s Market
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
